Philadelphia, PA (PRWEB) March 19, 2015
Pentec Health, Inc. today announced that its PROPLETE® product line has been awarded multiple international patents. The renal nutrition formulation now enjoys patent protection in Europe (United Kingdom), Asia (Japan, Hong Kong), Australia (Australia, New Zealand), Africa (South Africa) and North America (Canada). These awards are reflective of the Pentec growth strategy which includes expansion and growth beyond its U.S. presence.
“These patents clearly recognize the unique value of PROPLETE® and will provide the impetus for a global introduction of the product benefits to hemodialysis patients,” noted Joseph Cosgrove, Chairman, President and CEO of Pentec Health. “We will diligently explore all options to realizing both the healthcare and commercial value of PROPLETE®”.
PROPLETE®, Pentec’s proprietary Intradialytic Parenteral Nutrition (IDPN) supplement was developed through continued efforts to meet the renal nutrition needs of the dialysis community. PROPLETE® is effective in treating patients with malnutrition who are receiving hemodialysis for end stage chronic kidney disease. The inventor, Eileen Moore, CNSC, RD LD, Clinical Liaison Director-Renal Products at Pentec Health explains, “PROPLETE® formulations help to alleviate problems inherent in conventional IDPN solutions such as hyperglycemia while improving critical serum albumin levels.” She adds, “It is noteworthy that PROPLETE® demonstrated an increase in diabetic hemodialysis patients”.
Pentec is currently pursuing patents for PROPLETE® in additional countries. Pentec’s PROPLETE® and pharmacy compounding services are available in all 50 US states.
About Pentec Health, Inc.
For over 30 years, Pentec Health has been an industry leader in providing physician prescribed, custom prepared, patient-specific sterile medications that are intended for patient administration in the home as well as various alternate administration sites. Pentec Health is focused on providing renal nutritional products and services to dialysis centers for their malnourished dialysis patients, and as a Joint Commission accredited home care provider, the company offers in-home infusion services for highly complex conditions that are underserved by traditional home care providers. For more information on Pentec Health, Inc., visit http://www.pentechealth.com.